NCM Capital Management’s Merck MRK Stock Holding History

NCM Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.09M	Sell	17,387 -612	-3%	-$70.7K	0.75%	27
2025 Q4	$1.89M	Sell	17,999 -609	-3%	-$57.2K	0.7%	28
2025 Q3	$1.56M	Buy	18,608 +17	+0.1%	+$1.4K	0.61%	39
2025 Q2	$1.47M	Hold	18,591	–	–	0.6%	37
2025 Q1	$1.67M	Hold	18,591	–	–	0.75%	28
2024 Q4	$1.85M	Buy	18,591 +98	+0.5%	+$10.1K	0.83%	24
2024 Q3	$2.1M	Buy	18,493 +300	+2%	+$35.6K	1.01%	20
2024 Q2	$2.25M	Buy	18,193 +1,638	+10%	+$211K	1.18%	16
2024 Q1	$2.18M	Hold	16,555	–	–	1.22%	16
2023 Q4	$1.8M	Hold	16,555	–	–	1.09%	20
2023 Q3	$1.7M	Sell	16,555 -150	-0.9%	-$16.2K	1.21%	18
2023 Q2	$1.93M	Hold	16,705	–	–	1.34%	16
2023 Q1	$1.78M	Sell	16,705 -400	-2%	-$43.2K	1.33%	15
2022 Q4	$1.9M	Hold	17,105	–	–	1.25%	15
2022 Q3	$1.47M	Hold	17,105	–	–	1.11%	18
2022 Q2	$1.56M	Hold	17,105	–	–	1.09%	25
2022 Q1	$1.4M	Buy	17,105 +456	+3%	+$36K	0.88%	32
2021 Q4	$1.28M	Buy	+16,649	New	+$1.33M	1.13%	23

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NCM Capital Management's MRK Position: Q1 2026 in Review

NCM Capital Management reduced its Merck (MRK) stake by 3.4% in Q1 2026, selling an estimated $70.7K and leaving 17,387 shares worth $2.09M. The position accounts for 0.75% of the portfolio, ranked #27.

NCM Capital Management first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.25M in Q2 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

NCM Capital Management held 17,387 shares of Merck worth $2.09M as of Q1 2026.
NCM Capital Management sold 612 Merck shares in Q1 2026, an estimated $70.7K.
Merck made up 0.75% of NCM Capital Management's portfolio in Q1 2026, its #27 holding.
NCM Capital Management first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
NCM Capital Management's Merck position peaked at $2.25M in Q2 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on NCM Capital Management's 13F filing for Q1 2026, filed 15 May 2026.